Dose escalation trial of a novel calcium antagonist, AT877, in patients with aneurysmal subarachnoid haemorrhage

Acta neurochirurgica
M ShibuyaH Hidaka

Abstract

The initial dose-escalating clinical trial of a novel calcium antagonist, AT877, in patients with aneurysmal subarachnoid haemorrhage is reported. AT877 is characterized by its strong spasmolytic activity, its inhibition of intracellular calcium ion activity, and the inhibition of several protein kinases. A total of 113 patients (Hunt and Hess grades I to IV) who had undergone surgery within 3 days of aneurysmal rupture entered the study. Patients were divided into 5 groups according to the total daily dose of AT877: I: 20 mg; II: 40 mg; III: 60 mg; IV: 90 mg; and V: 120-180 mg. AT877 was given by intravenous infusion over 30 min two or three times a day for 14 days after surgery. Although AT877 did not completely abolish angiographic vasospasm, severe vasospasm was seen less frequently in patients given higher doses. Vasospasm was the cause of a poor clinical outcome (Glasgow outcome scale rating 3 or greater) in 19%, 7%, 9%, 8%, and 6% of the patients in groups I to V, respectively. The results indicated a favourable clinical effect of AT877 at doses above 40 mg per day. Only mild hypotension was seen, even when 60 mg of AT877 was infused over 30 min. AT877 appears to be effective in patients with subarachnoid haemorrhage. Pa...Continue Reading

References

Mar 1, 1975·Lancet·B Jennett, M Bond
Jul 1, 1986·Journal of Neurosurgery·M TakayasuH Hidaka
Aug 1, 1986·Journal of Neurosurgery·L M AuerT Auer
Jul 1, 1985·Stroke; a Journal of Cerebral Circulation·N F KassellG Nazar
Mar 17, 1983·The New England Journal of Medicine·G S AllenC R Transou

❮ Previous
Next ❯

Citations

Nov 19, 2010·Neurosurgical Review·Hiroshi TokimuraKazunori Arita
May 11, 2012·Neurosurgical Review·Hiroshi TokimuraKazunori Arita
Aug 24, 1999·Pharmacology & Therapeutics·N Ono-SaitoH Hidaka
Aug 2, 2007·Journal of Cardiovascular Pharmacology·James K LiaoKensuke Noma
Jul 24, 2010·Journal of Ophthalmology·Ryoichi AritaTatsuro Ishibashi
Mar 28, 2009·Microvascular Research·Matthew E Kutcher, Ira M Herman
Oct 24, 2002·Neurological Research·Agahan UnluBermans J Iskandar
Nov 15, 2008·Expert Opinion on Therapeutic Targets·Hwa Kyoung ShinCenk Ayata
Jan 25, 2007·BMC Urology·Peter T ChanLee Q Robinson
Aug 7, 2004·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Tatsuhiro Ishida
Jul 20, 2007·The Cochrane Database of Systematic Reviews·S M Dorhout MeesJ van Gijn
Jul 9, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Hiroaki Shimokawa, Akira Takeshita
Feb 1, 1994·Occupational and Environmental Medicine·K Y ChangH S Yu
Apr 15, 2006·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Masatomi Sasaki
Feb 28, 2002·Journal of Cardiovascular Pharmacology·Hiroaki Shimokawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.